Your browser doesn't support javascript.
loading
A novel method for high-sensitivity detection of SARS-CoV-2 using dual double-quenched fluorescence probes.
Zhu, Chunsen; Fang, Hao; Ma, Houshi; Xue, Jinbing; Li, Zeqin; Wu, Xi; Luo, Gangyin.
Affiliation
  • Zhu C; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
  • Fang H; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
  • Ma H; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
  • Xue J; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
  • Li Z; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
  • Wu X; Department of Geriatrics, The General Hospital of Western Theater Command, Chengdu, China.
  • Luo G; S uzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
Biosci Biotechnol Biochem ; 88(8): 892-899, 2024 Jul 22.
Article in En | MEDLINE | ID: mdl-38830810
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected many people around the world; fast and accurate detection of the virus can help control the spread of the virus. Reverse transcription-polymerase chain reaction (RT-PCR) is the gold standard method for SARS-CoV-2 detection. In this study, we improved the RT-PCR by proposing a novel method using dual double-quenched fluorescence probes. We used the improved probes to detect the plasmid DNA and RNA reference materials of SARS-CoV-2, respectively. The results show that, the background fluorescence intensity reduced by 50%, the fluorescence increment increased to 2.8 folds, and the Ct value significantly reduced by 3 or more, indicating that the detection sensitivity increased at least 8 times. In addition, we demonstrated that the improved probes have well performance in detecting SARS-CoV-2, with the minimum concentration of 6.2 copies/µL. This study will help biological companies develop better products for SARS-CoV-2 and other clinical pathogen infection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Fluorescent Dyes / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Biosci Biotechnol Biochem Journal subject: BIOQUIMICA / BIOTECNOLOGIA Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Fluorescent Dyes / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Biosci Biotechnol Biochem Journal subject: BIOQUIMICA / BIOTECNOLOGIA Year: 2024 Document type: Article Affiliation country: China